Cargando…

Garcinol Alone and in Combination With Cisplatin Affect Cellular Behavior and PI3K/AKT Protein Phosphorylation in Human Ovarian Cancer Cells

Garcinol is a plant-derived compound that has some physiological benefits to human cells. However, the effect of garcinol on ovarian cancer (OC) cell proliferation and apoptosis is unknown. The current study aimed to examine the effects of garcinol alone and in combination with cisplatin (DDP) on ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jie, Fang, Huan, Zhang, Jinguo, Guan, Wencai, Xu, Guoxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238453/ https://www.ncbi.nlm.nih.gov/pubmed/32489337 http://dx.doi.org/10.1177/1559325820926732

Ejemplares similares

Garcinol acts as an antineoplastic agent in human gastric cancer by inhibiting the PI3K/AKT signaling pathway
por: Zheng, Yuanyuan, et al.
Publicado: (2020)

MALAT1 affects ovarian cancer cell behavior and patient survival
por: Lin, Qunbo, et al.
Publicado: (2018)

A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer
por: Zhang, Jinguo, et al.
Publicado: (2021)

Biological Function of Ribosomal Protein L10 on Cell Behavior in Human Epithelial Ovarian Cancer
por: Shi, Jimin, et al.
Publicado: (2018)

Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

Pyridoxine 5′-phosphate oxidase is correlated with human breast invasive ductal carcinoma development
por: Ren, Weimin, et al.
Publicado: (2019)

Potential Role of Garcinol as an Anticancer Agent
por: Saadat, Nadia, et al.
Publicado: (2012)

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019)

Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Zhaoxia, et al.
Publicado: (2020)

Garcinol A Novel Inhibitor of Platelet Activation and Apoptosis
por: Cao, Hang, et al.
Publicado: (2019)

A Negative Feedback Loop Between NAMPT and TGF-β Signaling Pathway in Colorectal Cancer Cells
por: Lv, Xiaoqun, et al.
Publicado: (2021)

Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
por: Li, Feng, et al.
Publicado: (2015)

Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway
por: Zhang, Ying, et al.
Publicado: (2022)

Evaluation of hematopoietic stem cell expansion in the presence of garcinol
por: Habibi, Azam, et al.
Publicado: (2018)

Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2020)

Cellular stress-induced up-regulation of FMRP promotes cell survival by modulating PI3K-Akt phosphorylation cascades
por: Jeon, Se Jin, et al.
Publicado: (2011)

Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway
por: Xing, Feng, et al.
Publicado: (2019)

PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia
por: Xie, Youbang, et al.
Publicado: (2019)

Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis
por: Liu, Liang, et al.
Publicado: (2021)

MicroRNA-654-3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells
por: Niu, Yi-Chao, et al.
Publicado: (2020)

Astragalus membranaceus Enhances Myotube Hypertrophy through PI3K-Mediated Akt/mTOR Signaling Phosphorylation
por: Yeh, Tzu-Shao, et al.
Publicado: (2022)

Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer
por: Zhang, Lingyun, et al.
Publicado: (2021)

Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS Phosphorylation
por: Zhang, Yue-Ming, et al.
Publicado: (2018)

Garcinol inhibits the proliferation of endometrial cancer cells by inducing cell cycle arrest
por: Zhang, Min, et al.
Publicado: (2021)

Safety profile of 40% Garcinol from Garcinia indica in experimental rodents
por: Majeed, Muhammed, et al.
Publicado: (2018)

RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway
por: Liu, Mingming, et al.
Publicado: (2015)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
por: Wu, Yi-Hui, et al.
Publicado: (2020)

Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005)

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
por: NAVAEI, ZAHRA NASRPOUR, et al.
Publicado: (2022)

The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials
por: Li, Xin, et al.
Publicado: (2021)

Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells
por: Wang, Fanchen, et al.
Publicado: (2020)

Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT
por: Zhou, Hong-Hao, et al.
Publicado: (2016)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Li, Hefei, et al.
Publicado: (2021)

Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
por: Zhang, Lingyun, et al.
Publicado: (2017)

Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway
por: El-kott, Attalla Farag, et al.
Publicado: (2019)

Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA
por: Sandhiutami, Ni Made Dwi, et al.
Publicado: (2021)

Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA
por: Tang, Jianming, et al.
Publicado: (2018)

PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
por: Shu, Xiang-Rong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0nbj11115989152alau11svt0a